📰 Johnc Klock News
Johnc Klock News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Johnc Klock. Real-time updates on events, politics, business and more.
June 14, 2023
First Light Asset Management LLC lowered its holdings in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Get Rating) by 1.9% in the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 120,941 shares of the biotechnology company’s stock after selling 2,381 shares during the period. BioMarin Pharmaceutical comprises 1.2% of […]
June 14, 2023
Endurant Capital Management LP decreased its stake in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Get Rating) by 42.0% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 84,357 shares of the biotechnology company’s stock after selling 61,017 shares during the period. BioMarin Pharmaceutical comprises about […]
June 12, 2023
Grey Fox Wealth Advisors LLC bought a new stake in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Get Rating) during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 302 shares of the biotechnology company’s stock, valued at approximately $31,000. A number of other hedge funds and […]
June 11, 2023
Utah Retirement Systems decreased its holdings in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Get Rating) by 0.9% in the 4th quarter, HoldingsChannel reports. The firm owned 32,778 shares of the biotechnology company’s stock after selling 300 shares during the quarter. Utah Retirement Systems’ holdings in BioMarin Pharmaceutical were worth $3,392,000 as of its most recent filing […]
June 8, 2023
Gyon Technologies Capital Management LP raised its stake in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Get Rating) by 150.2% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 16,079 shares of the biotechnology company’s stock after buying an additional 9,653 shares during the period. Gyon Technologies […]
June 1, 2023
Shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Get Rating) have been given an average recommendation of “Hold” by the twenty-six analysts that are presently covering the company, MarketBeat.com reports. One equities research analyst has rated the stock with a sell recommendation, seven have given a hold recommendation and nine have assigned a buy recommendation to […]
May 31, 2023
Cigna Investments Inc. New purchased a new stake in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Get Rating) in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm purchased 2,031 shares of the biotechnology company’s stock, valued at approximately $210,000. Other institutional investors have also made changes […]
May 30, 2023
Alan B. Lancz & Associates Inc. trimmed its stake in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Get Rating) by 27.8% in the fourth quarter, Holdings Channel reports. The fund owned 1,300 shares of the biotechnology company’s stock after selling 500 shares during the period. Alan B. Lancz & Associates Inc.’s holdings in BioMarin Pharmaceutical […]
May 27, 2023
Comgest Global Investors S.A.S. grew its stake in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Get Rating) by 8.3% in the 4th quarter, according to its most recent filing with the SEC. The firm owned 136,908 shares of the biotechnology company’s stock after buying an additional 10,493 shares during the quarter. Comgest Global Investors S.A.S. owned 0.07% […]
May 22, 2023
Tekla Capital Management LLC grew its stake in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Get Rating) by 52.9% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 230,790 shares of the biotechnology company’s stock after acquiring an additional 79,843 shares during the period. […]